Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly: Aspirin in Reducing Events in the Elderly (ASPREE)

Author： Nelson M.R.   Reid C.M.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.20, Iss.12, 2003-01, pp. : 897-903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin for the Prevention of Cardiovascular Events in the Elderly

By Mahé I.  

Drugs & Aging, Vol. 20, Iss. 13, 2003-01 ,pp. : 999-1010

Adis International

Access to resources Recommend Favorite

Aspirin for Primary Prevention of Cardiovascular Events in the Elderly: Current Status and Future Directions

By Ward Stephanie A.   Demos Lisa  

Drugs & Aging, Vol. 29, Iss. 4, 2012-04 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite

Weigh risks and benefits of aspirin in the secondary or primary prevention of cardiovascular events in elderly individuals

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 8, 2004-08 ,pp. : 8-11

Adis International

Access to resources Recommend Favorite

Aspirin Use for the Primary Prevention of Cardiovascular Disease in the Elderly

By Sarbacker G. Blair   Lusk Kathleen A.   Flieller Lauren A.   Van Liew Jeffrey R.  

The Consultant Pharmacist, Vol. 31, Iss. 1, 2016-01 ,pp. : 24-32

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Non-compliance and discontinuation increases the risk of cardiovascular events in patients receiving low-dose aspirin

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 11, 2010-11 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite